Plovanic William J. 4
4 · OBALON THERAPEUTICS INC · Filed Aug 8, 2019
Insider Transaction Report
Form 4
Plovanic William J.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2019-08-06$4.00/sh+12,500$50,000→ 41,806 total - Purchase
Warrants (Right to Buy)
2019-08-06+9,375→ 9,375 totalExercise: $4.40From: 2019-08-06Exp: 2024-08-06→ Common Stock (9,375 underlying)
Footnotes (2)
- [F1]Reflects price paid to underwriters in Issuer's registered offering.
- [F2]Includes Restricted Shares that are subject to vesting.